Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCC

Clinical trial NCT04947241 · UNKNOWN

Trial details

NCT number: NCT04947241
Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Head and Neck Squamous Cell Carcinoma Neoadjuvant Therapy

Start date: 2020-12-15
Primary completion: 2026-01-15
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.